Medical News

RSS

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Today, Bayer HealthCare Pharmaceuticals Inc. and Bayer Schering Pharma AG sued Teva Pharmaceuticals USA, Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc. in the Northern District of Illinois (Chicago) for false advertising and patent infringement in connection with Teva's generic oral contraceptive, Gianvi™. Teva's product is sold as a generic version of Bayer HealthCare's leading oral contraceptive YAZ®.

16 Jun 2010

Inability of Mass. to curb health costs could be harbinger for national efforts

Last week, Massachusetts health reform "advocates celebrated a new report showing that, despite the devastating economic slump, the vast majority of Massachusetts residents had not dropped health insurance coverage." But also in the headlines were reports that "a state official called Massachusetts's decision to reject the vast majority of insurer rate hikes a 'train wreck' that would very likely lead to the insolvency of some companies.

16 Jun 2010

UOHI tests Canada's first in-hospital program to screen and treat patients for diabetes

The University of Ottawa Heart Institute is testing Canada's first in-hospital program to screen and treat patients for diabetes, a growing epidemic in much of the Western world. The program is expected to lead to new ways to identify and cope with one of the most important risk factors for heart disease, particularly in women.

16 Jun 2010

BIOCIUS Life Sciences, BlueSky Biotech collaborate to offer Sirtuin pre-validated assay solution

BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry's only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully-validated in a label-free functional assay.

16 Jun 2010

Galera Therapeutics completes Series 1 financing

Galera Therapeutics, a drug development company focused on novel therapeutics to protect against the side effects and increase the effectiveness of cancer treatment, today announced it has completed a Series 1 financing led by BioGenerator. Also participating in the round is Galera Angels, LLC, an angel investment group, and Analytical Bio-Chemistry Laboratories, Inc., of Columbia Missouri.

16 Jun 2010

Employer health costs slowing, but still face 9 percent increase in 2011

PriceWaterhouseCoopers is estimating that employer health costs will rise 9 percent in 2011, slightly less than they rose in 2010, Reuters reports. "The PriceWaterhouseCoopers team questioned 700 companies in 30 industries for the report. About 60 percent of Americans under the age of 65 get health insurance through an employer. Health benefits are often a major part of any employee compensation package. Most employers, 63 percent, offer a [managed-care] preferred provider organization or PPO, the survey found. And many have raised the deductible, with 43 percent having a deductible of $400 or more, compared to 25 percent in 2009."

16 Jun 2010

WellPoint to begin offering 'electronic' house calls

The Indianapolis Star: "Indianapolis-based health insurance giant WellPoint unveiled a new program to give its members access to doctors and other health-care providers via the Internet. The house call would be initiated by a patient logging in for a video chat from work to describe a sore throat, or a parent at home texting about a child with poison ivy.

16 Jun 2010

New research may help unravel cellular brain activity involved in human decisions

Crayfish make surprisingly complex, cost-benefit calculations, finds a University of Maryland study, opening the door to a new line of research that may help unravel the cellular brain activity involved in human decisions.

16 Jun 2010

Cytokine PharmaSciences completes misoprostol vaginal insert Phase II study

Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.

16 Jun 2010

Researchers examine rates of cancer in British white and British Indian population

British Indians have fewer cases of many different cancers including breast, prostate, colon and lung than the British white population, according to new research published in the British Journal of Cancer1 today (Wednesday).

16 Jun 2010

Aeterna Zentaris announces $12.1 million registered direct offering

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, announced today that it has received commitments from institutional investors to purchase US$12.1 million of securities in a registered direct offering.

16 Jun 2010

AMA: 20 percent of medical claims paid incorrectly, wastes billions

The American Medical Association said Monday that private insurers pay 20 percent of physician claims incorrectly in its third annual 'report card' on the insurance industry, The Associated Press reports.

16 Jun 2010

Elite medical schools rate poorly on social mission

A new study ranking the social mission of medical schools puts historically black colleges on top and some Northeast private schools at the bottom.

16 Jun 2010

FDA cautions on infant overdose risk with liquid Vitamin D

The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants.

16 Jun 2010

Teva prices $2.5 billion debt offering

Teva Pharmaceutical Industries Limited announced today that it successfully priced the offering, by its special purpose finance subsidiaries, of a debt offering in three tranches:

16 Jun 2010

Cheers, jeers for new federal rules on changes in health benefits

Kaiser Health News staff writers Phil Galewitz and Mary Agnes Carey report on the new "grandfather" rule: "Business groups gave mixed reviews Monday to new Obama administration rules limiting how much employers and insurers can change their health insurance plans - while remaining exempt from potentially costly new consumer protections.

16 Jun 2010

UIC receives $3M grant to evaluate comprehensive process for responding to patient harm events

The University of Illinois at Chicago's Institute for Patient Safety Excellence has received a $3 million grant to evaluate its comprehensive process for responding to patient harm events at nine other Chicago area hospitals.

16 Jun 2010

FDA clears Halt 2000GI Electrosurgical System for soft tissue ablation

Halt Medical, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared the Halt 2000GI™ Electrosurgical System for soft tissue ablation using radiofrequency energy. "This clearance to market is a major milestone for our customers, employees and investors," said Russ DeLonzor, President and Chief Operating Officer.

16 Jun 2010

High vitamin B levels in blood reduce lung cancer risk: Study

Regular intake of Vitamin B complex can reduce the risk of getting lung cancer, researchers have found. The research paper in the Journal of the American Medical Association however emphasized that quitting smoking was the best method to reduce the risk of lung cancer. It is too early to say that vitamin supplements can actually prevent lung cancer say researchers. Lung cancer kills nearly 1.3 million people globally each year according to the World Health Organization and 10 to 15 percent of smokers develop lung cancer.

15 Jun 2010

Expected 97% accuracy in ovarian cancer detection: Study underway

Now scientists in Melbourne have found a more effective test to detect ovarian cancer and hope to commence trials soon. This new test will check for two additional biomarkers that may indicate ovarian cancer in addition to conventional tests.

15 Jun 2010